...
首页> 外文期刊>Journal of Immunological Methods >Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.
【24h】

Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.

机译:使用IL-7进行人细胞毒性T淋巴细胞前体体外再刺激的基于肽的方案的优化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A variety of different methods for the in vitro restimulation of human cytotoxic T lymphocyte (CTL) precursors (CTLp) are in use. Our aim was to enhance the detection of circulating human CTLp in peripheral blood. We have developed a standardized and highly efficient method for restimulating CTLp. Synthetic peptides were used to restimulate cognate CTLp from peripheral blood mononuclear cells (PBMC), and effector CTL capable of lysing peptide-pulsed and virus infected targets were generated. The effects of several parameters on CTL specific for influenza A, EBV and HIV-1 were evaluated, and the optimum peptide concentration for CTL generation was established. Supplementation of initial cultures with IL-7 greatly enhanced peptide-specific lytic activity for all peptides tested and the dose-response relationship for IL-7 was delineated. A novel technique using peptide-MHC class I molecule tetramers to stain T cells bearing cognate T cell receptors permitted enumeration of antigen-specific CD8 + CTL during in vitro restimulation; IL-7 supplementation selectively expanded the population of peptide-specific CD8 + CTL. Importantly, this protocol, whilst enhancing the restimulation and lytic activity of secondary CTL, does not induce primary CTL in vitro. The improved efficiency with which CTL are generated in this system substantially enhances the sensitivity of CTL culture and the 51Cr release assay to detect low levels of CTL activity.
机译:使用了多种不同的方法来体外再刺激人细胞毒性T淋巴细胞(CTL)前体(CTLp)。我们的目标是增强对外周血中循环人CTLp的检测。我们已经开发出一种标准化且高效的方法来重新模拟CTLp。使用合成肽从外周血单核细胞(PBMC)重新刺激同源CTLp,并生成了能够裂解肽脉冲和病毒感染靶标的效应CTL。评估了几个参数对甲型流感,EBV和HIV-1特异的CTL的影响,并确定了用于CTL产生的最佳肽浓度。用IL-7补充初始培养物大大增强了所有测试肽的肽特异性裂解活性,并描绘了IL-7的剂量反应关系。使用肽-MHC I类分子四聚体对带有同源T细胞受体的T细胞染色的新技术允许在体外再刺激过程中枚举抗原特异性CD8 + CTL。 IL-7补充剂选择性地扩大了肽特异性CD8 + CTL的种群。重要的是,该协议在增强次级CTL的再刺激和裂解活性的同时,不会在体外诱导初级CTL。在该系统中生成CTL的效率提高,大大提高了CTL培养物的敏感性和51Cr释放测定法以检测低水平的CTL活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号